Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan S Go

Showing results (1-10 of 571) with videos related to

Pageof 58
Sort By:
The American Journal of Managed Care|May 22, 2004
Efficacy of anticoagulation for stroke prevention and risk stratification in atrial fibrillation: translating trials into clinical practiceAlan S Go
Nature Clinical Practice. Cardiovascular Medicine|November 3, 2005
Anticoagulants for stroke prevention in atrial fibrillation: what is the right rate and where do we go from here?Alan S Go
Managed Care (Langhorne, Pa.)|October 21, 2004
The importance of anticoagulation management servicesAlan S Go
Seminars in Nephrology|August 1, 2016
Cardiovascular Disease Consequences of CKDAlan S Go
The American Journal of Geriatric Cardiology|March 24, 2005
The epidemiology of atrial fibrillation in elderly persons: the tip of the icebergAlan S Go
The New England Journal of Medicine|May 15, 2009
The ACTIVE pursuit of stroke prevention in patients with atrial fibrillationAlan S Go
Journal of the American College of Cardiology|April 6, 2004
Economic implications of transesophageal echocardiography-guided cardioversion of atrial fibrillationMark Hlatky, Alan S Go
Archives of Internal Medicine|May 12, 2010
Rethinking the epidemiology of acute myocardial infarction: challenges and opportunitiesRobert W Yeh, Alan S Go
Archives of Internal Medicine|March 1, 2013
A new era in stroke prevention for atrial fibrillation: comment on "current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillationDaniel E Singer, Alan S Go
Current Opinion in Nephrology and Hypertension|September 12, 2022
The race coefficient in glomerular filtration rate-estimating equations and its removalChi-Yuan Hsu, Alan S Go
Pageof 58

Showing results (1-10 of 571) with videos related to

Sort By:
Pageof 58
The American Journal of Managed Care|May 22, 2004
Efficacy of anticoagulation for stroke prevention and risk stratification in atrial fibrillation: translating trials into clinical practiceAlan S Go
Nature Clinical Practice. Cardiovascular Medicine|November 3, 2005
Anticoagulants for stroke prevention in atrial fibrillation: what is the right rate and where do we go from here?Alan S Go
Managed Care (Langhorne, Pa.)|October 21, 2004
The importance of anticoagulation management servicesAlan S Go
Seminars in Nephrology|August 1, 2016
Cardiovascular Disease Consequences of CKDAlan S Go
The American Journal of Geriatric Cardiology|March 24, 2005
The epidemiology of atrial fibrillation in elderly persons: the tip of the icebergAlan S Go
The New England Journal of Medicine|May 15, 2009
The ACTIVE pursuit of stroke prevention in patients with atrial fibrillationAlan S Go
Journal of the American College of Cardiology|April 6, 2004
Economic implications of transesophageal echocardiography-guided cardioversion of atrial fibrillationMark Hlatky, Alan S Go
Archives of Internal Medicine|May 12, 2010
Rethinking the epidemiology of acute myocardial infarction: challenges and opportunitiesRobert W Yeh, Alan S Go
Archives of Internal Medicine|March 1, 2013
A new era in stroke prevention for atrial fibrillation: comment on "current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillationDaniel E Singer, Alan S Go
Current Opinion in Nephrology and Hypertension|September 12, 2022
The race coefficient in glomerular filtration rate-estimating equations and its removalChi-Yuan Hsu, Alan S Go
Pageof 58